Bill Text: IL HB3533 | 2021-2022 | 102nd General Assembly | Introduced

---

Bill Title: Amends the Illinois Controlled Substances Act. Provides that a prescriber shall provide information to all patients receiving a prescription for opioids on overdose prevention and the use of naloxone hydrochloride or another drug approved by the United States Food and Drug Administration for the complete or partial reversal of opioid depression.

Sponsorship: Partisan Bill (Democrat 2)

Status: (Introduced - Dead) 2021-04-23 - Rule 19(a) / Re-referred to Rules Committee [HB3533 Detail]

Download: Illinois-2021-HB3533-Introduced.html

---

102ND GENERAL ASSEMBLY State of Illinois 2021 and 2022 HB3533 Introduced , by Rep. Deb Conroy SYNOPSIS AS INTRODUCED:
720 ILCS 570/316.5 new
Amends the Illinois Controlled Substances Act. Provides that a prescriber shall provide information to all patients receiving a prescription for opioids on overdose prevention and the use of naloxone hydrochloride or another drug approved by the United States Food and Drug Administration for the complete or partial reversal of opioid depression.
LRB102 12524 KMF 17861 b
A BILL FOR
HB3533 LRB102 12524 KMF 17861 b
AN ACT concerning criminal law.
Be it enacted by the People of the State of Illinois,
represented in the General Assembly:
Section 5. The Illinois Controlled Substances Act is
amended by adding Section 316.5 as follows:
(720 ILCS 570/316.5 new)
Sec. 316.5. Naloxone Education. A prescriber shall provide
information to all patients receiving a prescription for
opioids on overdose prevention and the use of naloxone
hydrochloride or another drug approved by the United States
Food and Drug Administration for the complete or partial
reversal of opioid depression.